Invizius Announces Appointment of World-Renowned Nephrologist Professor Bernard Canaud to its Clinical Advisory Board

/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Manchester ,United Kingdom ,France ,Glasgow ,Glasgow City ,Edinburgh ,City Of ,Scotland ,America ,American ,French ,Richard Boyd ,Jonathan Milner ,Karolinska Institutet ,Bernard Canaud ,Candy Herbert ,Regulatory Agency ,Pennsylvania Convention Center ,Invizius Limited ,International Society Of Nephrology ,University Medical Centre Groningen ,American Society Of Nephrology ,University Of Manchester ,Edinburgh University Old College Capital ,Montpellier University School Of Medicine ,University Of Heidelberg ,French Society Of Nephrology ,University Of Strathclyde ,University Of Oxford ,Professor Bernard Canaud ,Clinical Advisory ,Emeritus Professor ,Montpellier University School ,Intensive Care Department ,Lapeyronie University Hospital ,Chief Medical Officer ,Fresenius Medical Care ,Middle East ,Latin America ,Chief Medical Scientist ,European Dialysis ,Transplant Association ,American Society ,International Society ,French Society ,Francophone De Dialyse ,Chief Executive Officer ,Professor Canaud ,United Kingdom Medicines ,Kidney Week ,Key Opinion Leaders ,Scottish Enterprise ,Invizius ,